Home
Welcome to Prostate Cancer Statistics!

Prostate Cancer Statistics
Prostate cancer is one of the most common types of cancer in men today, in fact, in the US, there is only one other type of cancer that is more common and that is skin cancer. The latest figures from the American Cancer Society suggested that in the United States of America, in 2011 approximately 250,000 new cases of prostate cancer will be diagnosed.
This is a truly shocking figure and one that Cancer researchers and scientists are trying desperately hard to reduce. So what is prostate cancer?
The prostate is a gland that sits in front of the rectum and underneath the bladder, it is only found in men. The gland tends to grow in size as men get older, and starts out as approximately the size of a walnut in a younger man, and carries on growing until the man reaches adulthood. If the prostate continues to grow it can start to press on the urethra making it difficult to pass urine, this is not necessarily cancer, but you should seek medical advice.
There are a number of different cell types in the prostate, but it is cells from the gland itself that are nearly always the cause of prostate cancer. Sometime prostate cancers grow and spread rapidly, but this is fairly unusual as most of them grow slowly. Some symptoms of the signs of prostate cancer include.
- Frequently needing the bathroom at night.
- Difficulty passing and maintaining a steady stream of urine.
- Evidence of blood in the urine.
- Pain was passing urine.
So here on prostate cancer statistics.com we going to delve a little deeper, and give you some specific statistics. To include.
We hope that by giving you these statistics that you will become better informed and more aware about this very common form of cancer in men. We will continue to be vigilant and report on any progress and research on our news and helpful links pages, so please come back often for more information.
We hope you find information on our website useful, and that it will inspire you to make a donation for prostate Cancer research.
